TB-402

DRUG3 trials

Sponsors

ThromboGenics

Conditions

HealthyProphylaxis of Venous Thromboembolic EventsTotal Knee Replacement Surgery

Phase 1

A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers

CompletedNCT00612196

ThromboGenicsHealthy

Start: 2007-03-31End: 2007-12-31Updated: 2014-04-07

Phase 2

Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

CompletedNCT00793234

ThromboGenicsTotal Knee Replacement Surgery

Start: 2008-12-31End: 2010-03-31Updated: 2014-04-07

Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery

CompletedNCT01344954

ThromboGenicsProphylaxis of Venous Thromboembolic Events

Start: 2011-04-30End: 2012-05-31Updated: 2012-08-23

Related Papers

Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.

2010-06-0118 citations